Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen
A completed clinical trial from Universität des Saarlandes evaluating quality of life in patients with seasonal allergic rhinitis treated wi…
-
FDA approval · 2016-12-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) filed by Organon LLC.
-
FDA label_change · 2016-12-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) by Organon LLC, resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602) [Phase 2]
A Phase 2 dose-ranging trial evaluating the efficacy and safety of ciclesonide HFA nasal aerosol in adults and adolescents 12 years and olde…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis
Clinical trial update on the efficacy, safety, and tolerability of a 4-week regimen of ciclesonide nasal spray (200 mcg) for intermittent an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406) [Phase 3]
Phase 3 study using an environmental exposure chamber to assess the onset of action of ciclesonide nasal spray for seasonal allergic rhiniti…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407) [Phase 3]
A Phase 3 trial evaluating onset of action of ciclesonide nasal spray for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401) [Phase 3]
A Phase 3 trial evaluating ciclesonide nasal spray for seasonal allergic rhinitis (hay fever) has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413) [Phase 3]
A Phase 3 clinical trial update reporting completion of a study evaluating ciclesonide nasal spray in adults with seasonal allergic rhinitis…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417) [Phase 3]
Phase 3 study assessing the safety and efficacy of ciclesonide in pediatric patients (6-11 years) with seasonal allergic rhinitis. The trial…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber [Phase 2]
A Phase 2 study comparing QAV680 to placebo for seasonal allergic rhinitis in an environmental exposure chamber, with the trial status liste…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo [Phase 2]
A Phase 2 trial evaluating a single-dose oral GSK835726 compared with placebo in seasonal allergic rhinitis has completed, using an allergen…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR) [Phase 2]
A Phase II study evaluating intranasal GSK256066 in combination with fluticasone propionate for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia [Phase 3]
Phase 3 trial evaluating the efficacy and safety of ciclesonide nasal spray in participants with seasonal allergic rhinitis in Russia. The s…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray [Phase 3]
Phase 3 safety trial in children with seasonal and perennial allergic rhinitis evaluating GW685698X aqueous nasal spray versus placebo has c…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action [Phase 3]
A Phase 3 trial in adolescents and adults 12 years and older with seasonal allergic rhinitis to assess onset of action has been completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Seasonal Allergic Rhinitis In Pediatric Subjects [Phase 3]
Phase 3 pediatric trial update for seasonal and perennial allergic rhinitis sponsored by GlaxoSmithKline; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Study In Adults And Adolescents With Seasonal Allergic Rhinitis. [Phase 3]
Phase 3 clinical trial update for adults and adolescents with seasonal allergic rhinitis, sponsored by GlaxoSmithKline (NCT00225823).
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Study In Adults And Adolescents With Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial in adults and adolescents with seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies [NA]
This clinical trial update reports completion of a study evaluating whether probiotics influence health-related quality of life in individua…
-
FDA approval · 2016-08-19FDA Approved: FEXOFENADINE HCL — Original Application (Strategic Sourcing Services)
FDA approves the original application for fexofenadine hydrochloride, a generic antihistamine, submitted by Strategic Sourcing Services.
-
FDA approval · 2016-06-23FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Montelukast from BluePoint Laboratories.
-
CLINICAL_TRIALS withdrawal · 2016-06-16Clinical Trial Update: Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo [NA]
A clinical trial evaluating Advair Diskus (fluticasone propionate/salmeterol) versus placebo for adolescents and adults with asthma and seas…
-
FDA approval · 2016-06-15FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) submitted by Chattem, Inc.
-
FDA approval · 2016-06-02FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Montelukast Sodium from Lannett Company, Inc., supporting a generic montelukast product.